Ionizing radiation causes its biological effects mainly through oxidative damage induced by reactive oxygen species. Previous studies showed that ozone oxidative preconditioning attenuated pathophysiological events mediated by reactive oxygen species. As inhalation of ozone induces lung injury, the aim of this study was to examine whether ozone oxidative preconditioning potentiates or attenuates the effects of irradiation on the lung. Rats were subjected to total body irradiation, with or without treatment with ozone oxidative preconditioning (0.72 mg/kg). Serum proinflammatory cytokine levels, oxidative damage markers, and histopathological analysis were compared at 6 and 72 h after total body irradiation. Irradiation significantly increased lung malondialdehyde levels as an end-product of lipoperoxidation. Irradiation also significantly decreased lung superoxide dismutase activity, which is an indicator of the generation of oxidative stress and an early protective response to oxidative damage. Ozone oxidative preconditioning plus irradiation significantly decreased malondialdehyde levels and increased the activity of superoxide dismutase, which might indicate protection of the lung from radiation-induced lung injury. Serum tumor necrosis factor alpha and interleukin-1 beta levels, which increased significantly following total body irradiation, were decreased with ozone oxidative preconditioning. Moreover, ozone oxidative preconditioning was able to ameliorate radiation-induced lung injury assessed by histopathological evaluation. In conclusion, ozone oxidative preconditioning, repeated low-dose intraperitoneal administration of ozone, did not exacerbate radiation-induced lung injury, and, on the contrary, it provided protection against radiation-induced lung damage.
Ionizing radiation causes its biological effects mainly through oxidative damage induced by reactive oxygen species. Previous studies showed that ozone oxidative preconditioning attenuated pathophysiological events mediated by reactive oxygen species. As inhalation of ozone induces lung injury, the aim of this study was to examine whether ozone oxidative preconditioning potentiates or attenuates the effects of irradiation on the lung. Rats were subjected to total body irradiation, with or without treatment with ozone oxidative preconditioning (0.72 mg/kg). Serum proinflammatory cytokine levels, oxidative damage markers, and histopathological analysis were compared at 6 and 72 h after total body irradiation. Irradiation significantly increased lung malondialdehyde levels as an end-product of lipoperoxidation. Irradiation also significantly decreased lung superoxide dismutase activity, which is an indicator of the generation of oxidative stress and an early protective response to oxidative damage. Ozone oxidative preconditioning plus irradiation significantly decreased malondialdehyde levels and increased the activity of superoxide dismutase, which might indicate protection of the lung from radiation-induced lung injury. Serum tumor necrosis factor alpha and interleukin-1 beta levels, which increased significantly following total body irradiation, were decreased with ozone oxidative preconditioning. Moreover, ozone oxidative preconditioning was able to ameliorate radiation-induced lung injury assessed by histopathological evaluation. In conclusion, ozone oxidative preconditioning, repeated low-dose intraperitoneal administration of ozone, did not exacerbate radiation-induced lung injury, and, on the contrary, it provided protection against radiation-induced lung damage.
Whole body exposure to ionizing radiation (IR) may trigger in humans and animals
multiple organ dysfunction directly related to an increase in cellular oxidative
stress due to overproduction of reactive oxidative species (ROS) from molecular
ionization (1,2). A large number of studies have indicated that DNA, lipids, and
proteins are attacked by free radicals induced by IR, thereby leading to significant
cellular damage (3). Additionally, ROS also
negatively impact the antioxidant defense mechanisms, reduce the intracellular
concentration of glutathione (GSH), and decrease the activities of superoxide
dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSHPx). Thus, the
organs become more susceptible to the deleterious effects of ROS (4). Therefore, any agent exhibiting antioxidant
effects can help protect cells from radiation toxicity.Many controlled trials have examined the validity of using ozone as a therapeutic
agent for the treatment of several disorders (5). Ozone administration has been shown to exert a protective effect
against liver damage induced by carbon tetrachloride and against renal
ischemic-reperfusion injury by an oxidative preconditioning mechanism that
stimulates antioxidant endogenous systems and modulates nitric oxide production
(6). The term “ozone oxidative
preconditioning” (OOP) refers to the administration of ozone at repeated nontoxic
doses that provide an adaptation to oxidative stress. Adaptation occurs through the
induction of enzymes or by activating metabolic pathways that maintain an
equilibrated redox balance, such as induction of SOD, increase in GSH levels, and
lowered peroxidation (7). Moreover, ozone
could prepare the host for the physiopathological conditions mediated by ROS (8). In a previous study, we demonstrated that
OOP could increase the endogenous antioxidant defense mechanism and induce an
adaptation to oxidative stress in rats, and thereby protect the animals from
radiation-induced hepatic and ileal injury (9). Although atoxic doses of ozone prevent radiation-induced organ damage,
ozone itself is a pulmonary irritant known to cause oxidative stress, inflammation,
and tissue injury (10).We hypothesize that ozone is one of the driving forces in initiating oxidative
stress, inflammation, and lung injury. Therefore, the goal of this study was to
determine, using a rat model of radiation-induced lung injury (RILI), the effects of
repeated intraperitoneal (ip) injections of ozone on the lung
before total body irradiation (TBI) and to determine whether OOP potentiates the
effects of IR or attenuates its effects by increasing the endogenous antioxidant
system.
Material and Methods
The experimental protocols were conducted with the approval of the Animal Research
Committee at Bulent Ecevit University, Zonguldak, Turkey. All animals were
maintained in accordance with the recommendations of the National Institutes of
Health Guidelines for the Care and Use of Laboratory Animals.
Animals and experimental procedures
Forty female Wistar rats weighing 200-230 g were housed individually in cages and
were allowed free access to standard rat chow and water before and after the
experiments. The animal rooms were windowless with temperature (22±2°C) and
lighting controls. The animals were fasted overnight before the experiments but
were given free access to water. They were anesthetized with 100 mg/kg ketamine
and 20 mg xylazine/kg body weight ip.The rats were divided into five equal groups. In the control group (group 1),
animals received daily ip injections of 0.9% saline for 5 days.
In the saline-treated and IR groups (groups 2 and 3), animals received daily
ip injections of 0.9% saline for 5 days. One hour after the
last injection of saline, the animals were exposed to a dose of 6 Gy TBI. Rats
were decapitated at 6 h (group 2) and 72 h (group 3) after exposure to
radiation. In OOP and IR groups (groups 4 and 5), an ozone/oxygen mixture was
administered ip at a dose of 0.7 mg/kg. The volume of gaseous
mixture administered to each animal was approximately 2.3 mL. OOP was performed
using 5 applications (once daily) of the ozone/oxygen mixture. One hour after
the last injection, the rats were irradiated with 6 Gy TBI in a single fraction.
Rats were decapitated at 6 h (group 4) and 72 h (group 5) after the exposure to
radiation.
Ozone production
Ozone was generated by an ozone generator, which allowed control of the gas flow
rate and ozone concentration in real time using a built-in ultraviolet
spectrometer and was administrated immediately at a dose of 0.72 mg/kg daily via
an ip route. The volume of the injected mixture was
approximately 2.3 mL. Oxidative preconditioning was performed using 5
applications (once daily) of the ozone/oxygen mixture. The ozone flow rate was
kept constant at 3 L/min, representing a concentration of 60 mg/mL and a gas
mixture of 97% oxygen+3% ozone. Tygon polymer tubes and single-use
silicone-treated polypropylene syringes (ozone resistant) were used throughout
the experiment to ensure containment of ozone and consistency of concentration
(11,12).
Total body irradiation
Computerized tomography simulation of rats was performed with 1-mm slices, and a
dose calculation was performed with the Eclipse treatment planning system
version 8.9 (Varian Medical Systems, USA). TBI was delivered to anesthetized
(ketamine 100 mg/kg intramuscular injection) rats in the prone position with a
single non-lethal dose of 6 Gy using a 6-MV linear accelerator (Varian Medical
Systems) at a dose rate of approximately 1 Gy/min with the source axis distance
technique and a 1.0-cm bolus material on the surface. Animals were returned to
their home cages following irradiation. Control animals were anesthetized but
were not exposed to radiation. All irradiations were performed between 7:00 and
8:30 am.
Sample collection
At the end of the experimental period, all animals were killed. Trunk blood was
collected for tumor necrosis factor alpha (TNF-α) and interleukin-1beta (IL-1β).
Tissue samples from the lung were fixed in formaldehyde for histological
analysis, while additional samples were stored at -80°C for the determination of
malondialdehyde (MDA) levels and SOD activity.
Biochemical analysis
TNF-α and IL-1β were assayed in serum samples for the evaluation of generalized
tissue damage. Serum IL-1β levels were measured using enzyme-linked
immunosorbent assay (ELISA) according to the manufacturer's instructions
(Bendermed International, Inc., USA). The levels of IL-1β were calculated from a
standard curve and are reported as pg/mL. Serum TNF-α levels were measured using
rat commercial ELISA reagents (eBioscience, USA) following the manufacturer's
protocol. The results are reported as pg/mL for TNF-α. Lung tissues were
homogenized in 10 volumes of 150 mM ice-cold KCl using a glass Teflon
homogenizer (Ultra Turrax IKA T18 Basic, Germany), after cutting the tissue into
small pieces with scissors (for 2 min at 5000 rpm). The homogenate was then
centrifuged at 5000 g for 15 min and the supernatant used for
analysis. High-performance liquid chromatographic (HPLC) analysis was performed
with the isocratic method using an Agilent 1200 HPLC system (USA) with a
commercial MDA kit (Immundiagnostik AG, Germany). The first step in determining
MDA was sample preparation with a derivatization reagent that transforms MDA
into a fluorescent product. Afterwards, the pH was optimized and the reaction
mixture (20 mL) was chromatographed on a reverse-phase C18 column (18.5 mm,
125×4 mm) at 30°C. The flow rate was 0.8 mL/min. Fluorimetric detection was
performed with excitation at 515 nm and emission at 553 nm. The detection limit
was 0.15 mM, and linearity was up to 100 mM. Protein concentrations of the
supernatants were determined by the Lowry method (13). Total SOD activity was determined according to the
method of Sun et al. (14). The principle
behind that method was based on inhibition of nitroblue tetrazolium (NBT)
reduction by a xanthine-xanthine oxidase system as a superoxide generator.
Activity was assessed in the ethanol phase of the liver homogenate after a
1.0-mL ethanol/chloroform mixture (5:3, v/v) was added to the same volume of the
hemolysate and centrifuged. One unit of SOD was defined as the amount of enzyme
causing 50% inhibition of the NBT reduction rate. Results are reported as nmol/g
protein for MDA and as U/g protein for SOD.
Histopathological analysis
The lung tissue samples were fixed in 10% buffered formalin solution, embedded in
paraffin, and cut into 5-µm sections. The sections were stained with
hematoxylin-eosin and examined under a light microscope by a blinded
pathologist. Sections were visualized under a Zeiss Imager A2 (Germany).
Statistical analysis
Statistical analysis was conducted with the SPSS version 13.0 software package
(IBM, USA). Continuous variables were given with mean, median, standard
deviation, minimum, and maximum values. Normality analyses were performed using
the Shapiro-Wilk test in order to evaluate the distribution of the data. Dual
and triple comparisons among groups were then performed by the Mann-Whitney
U-test and the Kruskal-Wallis test, respectively. P values <0.05 were
considered to be statistically significant.
Results
ELISA analysis indicated that animals in the irradiated group had significantly
increased serum TNF-α and IL-1β at both 6 and 72 h post-irradiation compared to
control animals (P=0.001). OOP reversed these changes significantly (P=0.001;
Tables 1 and 2). The outcomes of these proinflammatory parameters are
presented in Figures 1 and 2.
Figure 1
Serum tumor necrosis factor alpha (TNF-α) levels of control,
saline-treated+ionizing radiation (IR), or ozone oxidative
preconditioning (OOP)+IR groups decapitated at 6 or 72 h after
irradiation. Each group consisted of 8 rats. *P=0.001 compared to
control group; +P=0.001 compared to saline-treated group
(Mann-Whitney U-test).
Figure 2
Serum interleukin-1β (IL-1β) levels of control,
saline-treated+ionizing radiation (IR), or ozone oxidative
preconditioning (OOP)+IR groups decapitated at 6 or 72 h after
irradiation. Each group consisted of 8 rats. *P=0.001 compared to
control group; +P=0.001 compared to saline-treated group
(Mann-Whitney U-test).
The effects of TBI at 6 h after IR caused a statistically insignificant increase
in pulmonary MDA levels (P=0.145; Table
3), whereas values for lung MDA levels in the IR groups were still
found to be higher compared to the control group. These levels peaked at 72 h
after IR in all irradiated groups. OOP more effectively inhibited these
irradiation-induced elevations in lung MDA levels at 72 h after irradiation
compared to the radiation alone group (P=0.001; Figure 3). SOD activity in lung tissues significantly decreased at 6
and 72 h following irradiation, compared to the control group (P=0.001). OOP
significantly reversed lung SOD activity back to control values (P=0.001; Figure 4 and Table 4).
Figure 3
Malondialdehyde (MDA) levels in the lung tissues of control,
saline-treated+ionizing radiation (IR), or ozone oxidative
preconditioning (OOP)+IR groups decapitated at 6 or 72 h after
irradiation. Each group consisted of 8 rats. Circle: outlier. *P=0.001
compared to control group; +P=0.001 compared to
saline-treated group (Mann-Whitney U-test).
Figure 4
Superoxide dismutase (SOD) activity in the lung tissues of control,
saline-treated+ionizing radiation (IR), or ozone oxidative
preconditioning (OOP)+IR groups decapitated at 6 or 72 h after
irradiation. Each group consisted of 8 rats. *P=0.001 compared to
control group; +P=0.001 compared to saline-treated group
(Mann-Whitney U-test).
On histopathological examination, no abnormalities were seen in the lungs of the
control group animals (Figure 5A).
Alveolar area reduction as well as alveolar and bronchiolar hemorrhage were
observed in the lung tissues of the radiation-treated group at 6 h (Figure 5B). Severe alveolar and bronchiolar
hemorrhage, alveolar area reduction, interstitial congestion, and edema were
more prominent in the radiation-treated group at 72 h (Figure 5C). In the ozone-treated groups at 6 and 72 h,
alveolar area reduction, interstitial congestion, and alveolar and bronchiolar
hemorrhage were reduced compared with the radiation-treated groups at 6 and 72 h
(Figure 5D and E).
Figure 5
Histopathological findings of the groups. A, Normal
lung parenchyma in the control group [hematoxylin-eosin (HE), 100X].
B, Alveolar area reduction (thin arrow) and
alveolar hemorrhage (thick arrow) in radiation-treated group at 6 h (HE,
200X). C, Severe alveolar hemorrhage (thick arrow),
alveolar area reduction (thin arrow), interstitial congestion, and edema
in the radiation-treated group at 72 h (HE, 200X). D,
Reduced interstitial congestion and alveolar hemorrhage (thick arrow)
and expanded alveolar area (thin arrow) in ozone-treated groups at 6 h
(HE, 200X). E, Clearly reduced interstitial congestion
and alveolar hemorrhage and re-established alveolar structure (arrows)
in ozone-treated groups at 72 h (HE, 200X).
Discussion
A gas mixture containing ozone/oxygen used in medicine is known as medical ozone
therapy. Clinical studies have so far shown that ozone therapy appears useful in
diseases including peritonitis, infected wounds, chronic skin ulcers, initial
gangrene, burns, and advanced ischemic diseases (15). Ozone therapy has many modes of application including inhalation,
intravenous, intra-arterial, subcutaneous, intramuscular, intra-articular, or via
enema (16). Repeated rectal administration of
ozone has induced a sort of cross-tolerance to free radicals released after hepatic
and renal ischemia-reperfusion (7,17,18).
It has also been demonstrated that low doses of ozone increased antioxidant
endogenous systems involving GSH, SOD, and CAT, preparing the host to face
physiopathological conditions mediated by ROS (5,7,17,18). Ozone, probably
by means of an oxidative preconditioning mechanism, similar to ischemic
preconditioning, protected these organs from the damage produced by ROS, which
induced improvement in the antioxidant-prooxidant balance and the concomitant
preservation of the cell redox state (8,9,15).
On the other hand, it is very well known that inhalation of ozone can induce lung
injury characterized by inflammation, edema, and altered lung function (19). Ozone, a photochemical air pollutant, is a
very potent oxidant and reacts rapidly with biomolecules. The lungs are the most
affected organ, and pulmonary surfactant may be a target in ozone-induced lung
toxicity (20). Moreover, toxic effects of
ozone caused by excessive doses of inhaled ozone in the airways, as well as toxicity
to the endocrine, reproductive, and central nervous systems, have been described
(21,22). Although it has been demonstrated that an intrarectal or
ip ozone/oxygen mixture reduced ROS by stimulation and/or
preservation of the endogenous antioxidant systems in experimental models of liver
and renal ischemia-reperfusion and radiation-induced organ injury, respectively
(7,9,17,23,24), little is known
about its side effects that are specifically related to free radical formation and
irritation of the respiratory system.Experimental studies have shown that, in the case of RILI, the immediate release of
proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 after IR is closely related
to lung toxicity (24). In our study, OOP
reduced the release of radiation-induced TNF-α and IL-1β. On the other hand, studies
have shown that inhalation of ozone induces airway hyperactivity and interacts with
airway epithelium and alveolar macrophages to produce inflammation via increasing
inflammatory cytokines, including TNF-α and IL-1β (25,26). However, Bette et al.
(27) evaluated OOP with
ip administration of ozone, followed by a
tazobactam/piperacillin regimen in rats submitted to peritonitis, and found an
increase in survival rates and a decrease in proinflammatory cytokines, TNF-α and
IL-1β. Similarly, Zamora et al. (28) observed
a significant inhibitory effect of serum TNF-α release on mice pretreated with an
ozone/oxygen mixture by the ip route before induction of endotoxic
shock by lipopolysaccharides. These results suggest that ip
injections of a toxic dose of an ozone/oxygen mixture might modify the production
and/or release of TNF-α and IL-1β. The inhibitory effects of OOP on TNF-α and IL-1β
levels in the serum of irradiated rats might be a consequence of stimulation of
antioxidant defenses induced by ozone therapy.This point of view is scientifically supported by the fact that IR is associated with
increased production of free radicals (29),
which is reflected by the accumulation of oxidatively damaged cellular
macromolecules. Ionizing radiation may impair lung cells either directly via
generation of ROS (29) or indirectly via the
action on parenchymal and inflammatory cells through biological mediators (30). This process may subordinate the cellular
antioxidant defenses and lead to the accumulation of toxic levels of ROS. Our
results showed that, at 6 h after IR, rat pulmonary tissues did not have
significantly increased radiation-induced lipid peroxidation. However, lung MDA
levels were found to be higher in IR groups at 72 h compared to the control group,
and MDA levels in the group treated with ozone remained unchanged compared to the
IR-exposed group. In our study, we found that pulmonary SOD activity values of the
rats that received IR were lower than the control group suggesting the existence of
oxidative stress in these rats. This is evidence for the relationship between high
MDA levels and the occurrence of oxidative stress. In the OOP plus IR group, ozone
treatment induced a significant increase in lung SOD activity compared to the
radiation only group at 72 h after TBI. However, studies show that ozone inhalation
causes excessive production of cytotoxic mediators including pro-inflammatory
cytokines, ROS, and nitrogen intermediates by airway epithelial cells and activated
lung immune cells (31,32), Rodriguez et al. (33) demonstrated the efficacy of ip ozone pretreatment
in a fecal peritonitis model by means of reducing lung myeloperoxidase activity and
serum lipid peroxidation, and increasing antioxidant enzyme activities. Another
recent study showed that ip ozone therapy modulated the
inflammatory response and acute lung injury resulting from intra-abdominal infection
in rats (34).Therefore, the results of our study suggested that, in contrast with effects of ozone
inhalation on lung in different experimental models, OOP in rat lung conferred
protection from acute radiation damage. OOP managed this effect by reducing serum
levels of TNF-α and IL-1β, increasing SOD activity in lung tissue, and prevention of
exaggerated lipid peroxidation. Moreover, histological analyses of the lung tissues
72 h after IR showed acute inflammation, including alveolar area reduction and
alveolar and bronchiolar hemorrhage, and, compared with the saline-treated and IR
groups, OOP ameliorated RILI. Thus, our data regarding alleviation of RILI by OOP
were consistent with the findings of Yamanel et al. (35) in which ozone therapy provided protection against sepsis-induced
lung injury as evidenced by increased SOD and GSHPx activities and attenuation of
histopathological findings in acute lung injury.Because it is well established that ozone causes acute airway hyperreactivity after
exposure, it should also be stressed that the ip route of
administering the oxygen/ozone mixture did not exacerbate RILI, and OOP reduced
RILI.In the present study, it was demonstrated that OOP increased pulmonary SOD activity
and attenuated histopathological findings of RILI in rats exposed to TBI. Because
TBI decreased the total antioxidant capacity of organisms and the levels of known
antioxidants were depleted, the involvement of free radical scavengers to protect
against IR damage was highlighted. Recent insights into the mechanism of RILI have
shown that a new therapeutic approach is targeted against the continuous production
of ROS/reactive nitrogen species in an ongoing process that perpetuates lung injury
(36). Therefore, increasing antioxidant
capacity may be a strategy to prevent RILI. In animal models, the overexpression of
humancopper/zinc or manganese SOD genes delivered using liposomes or adenoviral
vectors has provided protection against RILI. This effect is probably also mediated
through decreased expression of IL-1, TNF, and TGF-β (37). Similarly, Rabbani et al. (38) showed that overexpression of extracellular SOD, one of the subtypes
of naturally occurring SOD, conferred protection against RILI. Other SOD-mimetic
agents have also shown promise in reducing RILI in animal studies (39). Thus, the findings of the present study
support OOP as an alternative therapy to attenuate deleterious effects of IR on
lung. Moreover, our research team previously presented the benefits of OOP in
radiation-induced liver and ileal injury. It was observed that OOP reduced oxidative
stress levels and tissue injury in rats exposed to TBI (9). However, in the present study, we did not examine the
mechanisms underlying OOP in animal models of RILI, and also no reports have
examined the mechanisms underlying OOP in animal models of radiation-induced organ
damage. On the other hand, several animal models have been developed to investigate
the mechanisms, characteristics, and pathophysiology of OOP (5-9,11,12,15,17,18,21,27,28,33,34). The current
evidence indicates that the protective effect of OOP is attributed to induction of
antioxidant enzyme gene expression (5,8,40).In conclusion, although it seems paradoxical that ozone, a potent oxidant agent, may
exert opposite effects and behave as an antioxidant agent when it is used at low
doses via ip administration, the procedure of OOP has demonstrated
convincingly protective and beneficial effects in disorders in which oxidative
stress and inflammation are involved, as occurs in RILI. Ozone treatment decreased
serum TNF-α and IL-1β levels, increased lung tissue SOD activity, and preserved
pulmonary MDA levels. Also the histological findings of RILI improved with ozone
treatment in rats. However, the major limitation of this study was evaluating the
short-term effects of radiation-induced pulmonary toxicity. At the studied dose and
administration route, ozone seemed to be of benefit in reducing irradiation-induced
oxidative injury of lung tissues. Therefore, further studies are required to
identify late effects of OOP. Additional studies using high-dose thoracic radiation
will determine whether administration of ozone can prevent radiation-induced
pneumonitis and/or fibrotic remodeling in the lung.
Authors: C Peralta; O S León; C Xaus; N Prats; E C Jalil; E S Planell; P Puig-Parellada; E Gelpí; J Roselló-Catafau Journal: Free Radic Res Date: 1999-09
Authors: M W Epperly; J A Bray; S Krager; L M Berry; W Gooding; J F Engelhardt; R Zwacka; E L Travis; J S Greenberger Journal: Int J Radiat Oncol Biol Phys Date: 1999-01-01 Impact factor: 7.038
Authors: K Arsalane; P Gosset; D Vanhee; C Voisin; Q Hamid; A B Tonnel; B Wallaert Journal: Am J Respir Cell Mol Biol Date: 1995-07 Impact factor: 6.914
Authors: Tao Qiu; Zhi-Shun Wang; Xiu-Heng Liu; Hui Chen; Jiang-Qiao Zhou; Zhi-Yuan Chen; Min Wang; Guan-Jun Jiang; Lei Wang; Gang Yu; Long Zhang; Ye Shen; Lu Zhang; Li He; Hua-Xin Wang; Wen-Jing Zhang Journal: Exp Ther Med Date: 2017-03-08 Impact factor: 2.447
Authors: Bjorn Baselet; Ronald B Driesen; Emma Coninx; Niels Belmans; Tom Sieprath; Ivo Lambrichts; Winnok H De Vos; Sarah Baatout; Pierre Sonveaux; An Aerts Journal: Front Pharmacol Date: 2020-03-13 Impact factor: 5.810